Meraviglia P - Search Results

1

Use of lopinavir/ritonavir in HIV-infected patients failing a first-line protease-inhibitor-containing HAART.

Bongiovanni M, Chiesa E, Di Biagio A, Meraviglia P, Capetti A, Tordato F, Cicconi P, Biasi P, Bini T, d'Arminio Monforte A. Bongiovanni M, et al. Among authors: meraviglia p. J Antimicrob Chemother. 2005 Jun;55(6):1003-7. doi: 10.1093/jac/dki113. Epub 2005 Apr 11. J Antimicrob Chemother. 2005. PMID: 15824089

2

Virological success of lopinavir/ritonavir salvage regimen is affected by an increasing number of lopinavir/ritonavir-related mutations.

Bongiovanni M, Bini T, Adorni F, Meraviglia P, Capetti A, Tordato F, Cicconi P, Chiesa E, Cordier L, Cargnel A, Landonio S, Rusconi S, d'Arminio Monforte A. Bongiovanni M, et al. Among authors: meraviglia p. Antivir Ther. 2003 Jun;8(3):209-14. Antivir Ther. 2003. PMID: 12924537 Clinical Trial.

3

Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.

Meraviglia P, Schiavini M, Castagna A, Viganò P, Bini T, Landonio S, Danise A, Moioli MC, Angeli E, Bongiovanni M, Hasson H, Duca P, Cargnel A. Meraviglia P, et al. HIV Med. 2004 Sep;5(5):334-43. doi: 10.1111/j.1468-1293.2004.00232.x. HIV Med. 2004. PMID: 15369508 Free article.

4

Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals.

Bongiovanni M, Cicconi P, Landonio S, Meraviglia P, Testa L, Di Biagio A, Chiesa E, Tordato F, Bini T, Monforte Ad. Bongiovanni M, et al. Among authors: meraviglia p. Int J Antimicrob Agents. 2005 Jul;26(1):88-91. doi: 10.1016/j.ijantimicag.2005.03.003. Int J Antimicrob Agents. 2005. PMID: 15878262

5

Predictive factors of hyperlipidemia in HIV-infected subjects receiving lopinavir/ritonavir.

Bongiovanni M, Bini T, Cicconi P, Landonio S, Meraviglia P, Testa L, Di Biagio A, Chiesa E, Tordato F, Biasi P, Adorni F, Monforte AD. Bongiovanni M, et al. Among authors: meraviglia p. AIDS Res Hum Retroviruses. 2006 Feb;22(2):132-8. doi: 10.1089/aid.2006.22.132. AIDS Res Hum Retroviruses. 2006. PMID: 16478394

6

Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients.

Orlando G, Meraviglia P, Cordier L, Meroni L, Landonio S, Giorgi R, Fasolo M, Faggion I, Riva A, Zambelli A, Beretta R, Gubertini G, Dedivitiis G, Jacchetti G, Cargnel A. Orlando G, et al. Among authors: meraviglia p. HIV Med. 2006 Nov;7(8):549-57. doi: 10.1111/j.1468-1293.2006.00420.x. HIV Med. 2006. PMID: 17105515 Free article.

7

Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis.

Micheli V, Regazzi M, Dickinson L, Meraviglia P, Villani P, Khoo SH, Viganò P, Cordier L, Cusato M, Duca P, Orlando G, Rizzardini G, Back DJ, Cargnel A. Micheli V, et al. Among authors: meraviglia p. Ther Drug Monit. 2008 Jun;30(3):306-13. doi: 10.1097/FTD.0b013e318177209e. Ther Drug Monit. 2008. PMID: 18520602 Free PMC article. Clinical Trial.

8

Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.

Skowron G, Spritzler JG, Weidler J, Robbins GK, Johnson VA, Chan ES, Asmuth DM, Gandhi RT, Lie Y, Bates M, Pollard RB; NIH/NIAID ACTG 384 Protocol Team and Monogram Biosciences. Skowron G, et al. J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):250-8. doi: 10.1097/QAI.0b013e3181938faf. J Acquir Immune Defic Syndr. 2009. PMID: 19194319 Free PMC article. Clinical Trial.

9

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.

Bracciale L, Colafigli M, Zazzi M, Corsi P, Meraviglia P, Micheli V, Maserati R, Gianotti N, Penco G, Setti M, Di Giambenedetto S, Butini L, Vivarelli A, Trezzi M, De Luca A. Bracciale L, et al. Among authors: meraviglia p. J Antimicrob Chemother. 2009 Sep;64(3):607-15. doi: 10.1093/jac/dkp246. Epub 2009 Jul 16. J Antimicrob Chemother. 2009. PMID: 19608581

10

Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.

Piconi S, Trabattoni D, Gori A, Parisotto S, Magni C, Meraviglia P, Bandera A, Capetti A, Rizzardini G, Clerici M. Piconi S, et al. Among authors: meraviglia p. AIDS. 2010 Aug 24;24(13):1991-2000. doi: 10.1097/QAD.0b013e32833c93ce. AIDS. 2010. PMID: 20651586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters